New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
09:58 EDTSPEXSpherix, Fullife Healthcare sign supply and license agreement
Spherix Incorporated and Fullife Healthcare announced the signing of a supply and license agreement for the use of D-tagatose in nutraceutical products in India. Under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. Financial terms of the agreement were not disclosed.
News For SPEX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
06:11 EDTSPEXSpherix announces VTech/Uniden cases to get underway
Spherix provided an update on the company's cases against VTech and Uniden in the Northern District of Texas and announcing that those litigations are moving forward. The cases against VTech and Uniden have been stayed since September 10, 2015, pending the outcome of two Inter Partes Re-examination, or IPR, proceedings that VTech and Uniden filed in the U.S. Patent Office. The IPR was initiated on only certain claims of two of the patents that Spherix has asserted. Other patents asserted against these defendants were not part of the IPR and not impacted by the IPR decision.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use